Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.15 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.61.
Market Cap
8.15T
Revenue
4.59T
Profits
200.69B
PE Ratio
40.61
Profit Margin
4.37%
Dividend Yield
0.44%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 875.77B | -2.27% | 1,327,008 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 551.71B | 1.09% | 3,809,131 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 368.50B | -0.87% | 2,760,988 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 354.23B | -0.96% | 6,086,757 | 449.71B |
| 5 | NVS | Novartis AG | 284.47B | 0.88% | 734,863 | 56.58B |
| 6 | AZN | AstraZeneca PLC | 281.66B | 1.41% | 830,099 | 60.44B |
| 7 | MRK | Merck & Co., Inc. | 277.71B | 0.95% | 3,569,655 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 197.47B | -1.43% | 11,703,619 | 50.57B |
| 9 | AMGN | Amgen Inc. | 174.27B | -1.05% | 1,175,549 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 163.52B | 0.39% | 1,187,635 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 160.99B | 0.07% | 3,208,894 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 155.55B | 4.30% | 1,353,094 | 10.58B |
| 13 | ABT | Abbott Laboratories | 151.85B | 3.21% | 7,544,639 | 45.13B |
| 14 | PFE | Pfizer Inc. | 143.97B | -0.28% | 19,963,901 | 63.32B |
| 15 | CVS | CVS Health Corporation | 122.26B | -0.07% | 4,881,921 | 405.62B |
| 16 | SYK | Stryker Corporation | 120.34B | 2.33% | 2,375,106 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 117.09B | 0.60% | 7,586,599 | 48.48B |
| 18 | DHR | Danaher Corporation | 115.69B | 0.95% | 1,845,016 | 24.78B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.98B | 0.08% | 860,033 | 12.22B |
| 20 | SNY | Sanofi | 103.16B | 1.52% | 1,768,492 | 54.60B |
| 21 | GSK | GSK plc | 100.34B | 1.15% | 2,239,559 | 43.29B |
| 22 | MDT | Medtronic plc | 98.92B | 1.18% | 6,875,944 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 94.70B | 0.92% | 614,659 | 76.39B |
| 24 | MCK | McKesson Corporation | 92.98B | 1.70% | 587,900 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 85.61B | 0.40% | 1,119,281 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 83.27B | 6.34% | 10,852,227 | 20.61B |
| 27 | CI | The Cigna Group | 75.61B | 0.19% | 795,322 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.87B | -10.09% | 2,495,282 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.20B | -0.12% | 3,297,195 | 28.34B |
| 30 | COR | Cencora, Inc. | 51.04B | 1.80% | 1,181,165 | 328.68B |
| 31 | ARGX | argenx SE | 48.90B | -2.41% | 242,292 | 4.74B |
| 32 | EW | Edwards Lifesciences Corporation | 47.28B | 0.89% | 2,688,242 | 6.30B |
| 33 | MDLN | Medline Inc. | 47.21B | -0.69% | 5,575,703 | 29.14B |
| 34 | CAH | Cardinal Health, Inc. | 46.96B | 2.72% | 1,435,673 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 43.20B | 3.57% | 388,780 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 39.65B | -0.70% | 3,384,380 | 17.35B |
| 37 | HLN | Haleon plc | 39.33B | 2.06% | 7,494,332 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 39.19B | -0.87% | 2,194,687 | 22.23B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.21B | -0.29% | 447,239 | 4.29B |
| 40 | HUM | Humana Inc. | 36.51B | -0.32% | 1,006,940 | 137.20B |
| 41 | WAT | Waters Corporation | 32.72B | 1.22% | 504,151 | 3.77B |
| 42 | ZTS | Zoetis Inc. | 32.49B | 4.41% | 6,294,664 | 9.53B |
| 43 | ONC | BeOne Medicines AG | 32.43B | -0.54% | 128,894 | 5.70B |
| 44 | A | Agilent Technologies, Inc. | 31.59B | 0.08% | 960,180 | 7.07B |
| 45 | ALC | Alcon Inc. | 31.25B | 3.52% | 2,123,743 | 10.63B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.55B | -1.34% | 1,173,574 | - |
| 47 | RPRX | Royalty Pharma plc | 30.06B | -1.21% | 2,015,018 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.76B | 1.62% | 626,763 | 5.54B |
| 49 | IQV | IQVIA Holdings Inc. | 28.72B | 1.73% | 731,585 | 16.63B |
| 50 | CNC | Centene Corporation | 28.62B | -0.55% | 2,189,252 | 178.33B |
| 51 | BIIB | Biogen Inc. | 28.32B | -0.58% | 563,521 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 28.01B | 1.33% | 3,293,959 | 20.98B |
| 53 | NTRA | Natera, Inc. | 27.89B | 4.49% | 1,548,852 | 2.50B |
| 54 | VEEV | Veeva Systems Inc. | 26.68B | 2.90% | 1,478,400 | 3.20B |
| 55 | DXCM | DexCom, Inc. | 24.95B | 4.93% | 7,133,508 | 4.82B |
| 56 | PHG | Koninklijke Philips N.V. | 24.16B | 3.13% | 985,150 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.04B | -0.40% | 154,951 | 3.17B |
| 58 | INSM | Insmed Incorporated | 23.15B | -2.15% | 2,499,869 | 819.56M |
| 59 | BNTX | BioNTech SE | 22.35B | -1.28% | 604,892 | 3.23B |
| 60 | MTD | Mettler-Toledo International Inc. | 21.63B | 3.75% | 149,791 | 4.09B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.48B | 0.38% | 265,455 | 3.22B |
| 62 | ILMN | Illumina, Inc. | 21.42B | -0.69% | 948,039 | 4.39B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.15B | 2.38% | 428,852 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 21.05B | 2.52% | 271,360 | 14.14B |
| 65 | STE | STERIS plc | 21.02B | 1.05% | 369,174 | 5.94B |
| 66 | ROIV | Roivant Sciences Ltd. | 20.41B | -2.63% | 2,494,634 | 13.31M |
| 67 | VTRS | Viatris Inc. | 19.22B | 0.12% | 4,872,868 | 14.56B |
| 68 | MRNA | Moderna, Inc. | 19.07B | -2.00% | 3,364,536 | 2.23B |
| 69 | INCY | Incyte Corporation | 19.01B | -0.18% | 515,716 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.92B | -0.12% | 628,496 | 21.46B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.50B | 1.88% | 1,273,402 | 8.41B |
| 72 | GMAB | Genmab A/S | 16.12B | -0.75% | 2,398,675 | 3.90B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.77B | -0.98% | 790,063 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.67B | -1.83% | 407,710 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.38B | 0.16% | 354,376 | 4.44B |
| 76 | RGC | Regencell Bioscience Holdings Limited | 13.68B | -3.20% | 50,657 | - |
| 77 | SOLV | Solventum Corporation | 13.16B | 2.34% | 762,611 | 8.26B |
| 78 | DVA | DaVita Inc. | 12.89B | 0.52% | 440,529 | 13.84B |
| 79 | PEN | Penumbra, Inc. | 12.84B | 1.24% | 280,941 | 1.45B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 12.66B | -2.27% | 2,398,523 | 579.96M |
| 81 | SNN | Smith & Nephew plc | 12.65B | 2.61% | 822,537 | 6.16B |
| 82 | EXEL | Exelixis, Inc. | 12.59B | -0.10% | 1,468,763 | 2.38B |
| 83 | GH | Guardant Health, Inc. | 12.51B | -0.62% | 716,664 | 1.08B |
| 84 | SMMT | Summit Therapeutics Inc. | 12.33B | -5.81% | 2,667,989 | - |
| 85 | MEDP | Medpace Holdings, Inc. | 12.04B | 1.51% | 209,203 | 2.68B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.01B | -2.09% | 1,563,786 | 1.06B |
| 87 | FMS | Fresenius Medical Care AG | 11.92B | 2.92% | 647,509 | 22.32B |
| 88 | COO | The Cooper Companies, Inc. | 11.91B | 2.38% | 1,922,400 | 4.15B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | -1.48% | 180,023 | 1.13B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 11.64B | -0.68% | 335,448 | 708.24M |
| 91 | BTSG | BrightSpring Health Services, Inc. | 11.60B | -2.61% | 1,332,273 | 13.65B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.55B | 0.26% | 1,547,214 | 3.58B |
| 93 | ALGN | Align Technology, Inc. | 11.40B | 1.18% | 557,597 | 4.10B |
| 94 | GMED | Globus Medical, Inc. | 10.74B | 3.28% | 1,099,953 | 3.10B |
| 95 | RVTY | Revvity, Inc. | 10.70B | 2.03% | 468,077 | 2.90B |
| 96 | EHC | Encompass Health Corporation | 10.68B | 0.94% | 679,861 | 6.07B |
| 97 | PODD | Insulet Corporation | 10.56B | 3.34% | 971,835 | 2.90B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.32B | -4.40% | 945,589 | 622.01M |
| 99 | UHS | Universal Health Services, Inc. | 10.31B | 0.95% | 341,953 | 17.76B |
| 100 | ENSG | The Ensign Group, Inc. | 10.26B | -0.35% | 265,102 | 5.27B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.17B | -1.25% | 1,092,533 | 105.82M |
| 102 | ELAN | Elanco Animal Health Incorporated | 9.96B | 0.40% | 5,644,507 | 4.89B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 9.62B | -3.98% | 2,499,734 | 3.24B |
| 104 | MOH | Molina Healthcare, Inc. | 9.59B | -0.51% | 625,799 | 43.10B |
| 105 | MASI | Masimo Corporation | 9.36B | 0.13% | 1,264,273 | 1.56B |
| 106 | BAX | Baxter International Inc. | 9.16B | 2.54% | 3,987,156 | 11.32B |
| 107 | ABVX | ABIVAX Société Anonyme | 9.11B | -2.12% | 654,969 | 5.37M |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 8.80B | -7.85% | 219,780 | 7.46M |
| 109 | ICLR | ICON Public Limited Company | 8.70B | -2.15% | 349,853 | 8.10B |
| 110 | KRYS | Krystal Biotech, Inc. | 8.63B | -4.47% | 209,248 | 417.30M |
| 111 | GKOS | Glaukos Corporation | 8.37B | -0.99% | 588,093 | 551.35M |
| 112 | IBRX | ImmunityBio, Inc. | 8.31B | -0.50% | 10,113,711 | 140.98M |
| 113 | HSIC | Henry Schein, Inc. | 8.30B | 0.21% | 615,875 | 13.38B |
| 114 | HALO | Halozyme Therapeutics, Inc. | 7.99B | 0.39% | 1,023,961 | 1.51B |
| 115 | NUVL | Nuvalent, Inc. | 7.90B | -2.31% | 286,517 | - |
| 116 | TEM | Tempus AI, Inc. | 7.78B | -1.41% | 4,566,034 | 1.36B |
| 117 | OSCR | Oscar Health, Inc. | 7.60B | 8.28% | 9,579,169 | 13.30B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.54B | 13.85% | 785,562 | 2.59B |
| 119 | ATR | AptarGroup, Inc. | 7.44B | 1.72% | 208,604 | 3.87B |
| 120 | CRL | Charles River Laboratories International, Inc. | 7.22B | -0.66% | 1,114,979 | 4.03B |
| 121 | HQY | HealthEquity, Inc. | 7.02B | 1.06% | 618,505 | 1.31B |
| 122 | PCVX | Vaxcyte, Inc. | 6.97B | -7.86% | 1,160,617 | - |
| 123 | QGEN | Qiagen N.V. | 6.96B | 2.06% | 2,348,830 | 2.10B |
| 124 | TECH | Bio-Techne Corporation | 6.93B | 2.19% | 2,709,964 | 1.21B |
| 125 | GRFS | Grifols, S.A. | 6.56B | 2.81% | 430,722 | 8.58B |
| 126 | KYMR | Kymera Therapeutics, Inc. | 6.53B | -3.38% | 390,983 | 51.48M |
| 127 | BRKR | Bruker Corporation | 6.52B | -0.05% | 1,386,269 | 3.46B |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.50B | -1.07% | 253,033 | 74.06M |
| 129 | CELC | Celcuity Inc. | 6.40B | -3.78% | 486,198 | - |
| 130 | ALKS | Alkermes plc | 6.22B | -0.37% | 1,038,064 | 1.56B |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 733,737 | 15.00M |
| 132 | SYRE | Spyre Therapeutics, Inc. | 6.09B | -6.38% | 657,641 | - |
| 133 | LNTH | Lantheus Holdings, Inc. | 6.04B | -1.26% | 925,735 | 1.55B |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.96B | -3.94% | 353,144 | 217.17M |
| 135 | CORT | Corcept Therapeutics Incorporated | 5.94B | -1.92% | 446,831 | 769.10M |
| 136 | APGE | Apogee Therapeutics, Inc. | 5.90B | -2.93% | 506,244 | - |
| 137 | RGEN | Repligen Corporation | 5.90B | 1.72% | 1,047,339 | 763.34M |
| 138 | PACS | PACS Group, Inc. | 5.86B | -1.17% | 465,397 | 5.43B |
| 139 | CHE | Chemed Corporation | 5.86B | 2.05% | 131,548 | 2.54B |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 5.84B | -6.33% | 615,981 | 569.61M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.81B | -1.92% | 487,243 | 827.11M |
| 142 | TFX | Teleflex Incorporated | 5.81B | 1.21% | 562,018 | 2.13B |
| 143 | BLCO | Bausch + Lomb Corporation | 5.73B | -0.19% | 324,037 | 5.21B |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.69B | -3.74% | 522,932 | - |
| 145 | BLTE | Belite Bio, Inc | 5.63B | 0.05% | 84,236 | - |
| 146 | TGTX | TG Therapeutics, Inc. | 5.60B | 0.03% | 935,430 | 700.35M |
| 147 | CGON | CG Oncology, Inc. | 5.57B | -5.72% | 630,648 | 5.07M |
| 148 | COGT | Cogent Biosciences, Inc. | 5.37B | -3.79% | 994,157 | - |
| 149 | IMVT | Immunovant, Inc. | 5.36B | -4.18% | 840,091 | - |
| 150 | HIMS | Hims & Hers Health, Inc. | 5.27B | -9.16% | 20,964,320 | 2.37B |
| 151 | AVTR | Avantor, Inc. | 5.20B | - | 5,843,388 | 6.55B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.16B | -1.77% | 311,331 | 7.50M |
| 153 | LEGN | Legend Biotech Corporation | 5.07B | -0.87% | 1,319,664 | 1.14B |
| 154 | LQDA | Liquidia Corporation | 5.02B | -0.83% | 988,607 | 288.07M |
| 155 | STVN | Stevanato Group S.p.A. | 4.85B | -1.20% | 269,988 | 1.39B |
| 156 | CRSP | CRISPR Therapeutics AG | 4.66B | -0.29% | 1,229,423 | 4.10M |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 4.47B | -5.14% | 371,695 | 1.34M |
| 158 | SHC | Sotera Health Company | 4.39B | 0.79% | 2,457,019 | 1.19B |
| 159 | CAI | Caris Life Sciences, Inc. | 4.26B | 3.57% | 3,963,033 | 907.29M |
| 160 | RDNT | RadNet, Inc. | 4.25B | 3.18% | 266,634 | 2.14B |
| 161 | HNGE | Hinge Health, Inc. | 4.23B | 0.24% | 562,567 | 646.34M |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.21B | -1.49% | 78,430 | 274.48M |
| 163 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.14B | -4.69% | 376,093 | 754.05M |
| 164 | MANE | Veradermics, Incorporated | 4.14B | 0.86% | 332,510 | - |
| 165 | BLLN | BillionToOne, Inc. | 4.02B | 5.66% | 410,187 | 354.54M |
| 166 | TVTX | Travere Therapeutics, Inc. | 4.00B | 0.94% | 848,620 | 536.20M |
| 167 | LIVN | LivaNova PLC | 3.95B | 2.69% | 255,307 | 1.43B |
| 168 | NAMS | NewAmsterdam Pharma Company N.V. | 3.87B | -5.04% | 1,392,760 | 22.57M |
| 169 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.13% | 3,295,392 | 596.96M |
| 170 | MMSI | Merit Medical Systems, Inc. | 3.82B | 4.32% | 579,099 | 1.54B |
| 171 | AMRX | Amneal Pharmaceuticals, Inc. | 3.81B | 0.17% | 524,920 | 3.05B |
| 172 | NVST | Envista Holdings Corporation | 3.78B | 0.13% | 3,577,776 | 2.81B |
| 173 | IRTC | iRhythm Holdings, Inc. | 3.68B | -1.70% | 516,123 | 787.85M |
| 174 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.67B | -5.41% | 392,180 | 18.07M |
| 175 | DOCS | Doximity, Inc. | 3.62B | 3.37% | 4,015,043 | 644.86M |
| 176 | WAY | Waystar Holding Corp. | 3.56B | 3.57% | 1,395,619 | 1.16B |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.56B | -2.85% | 949,979 | 1.10B |
| 178 | OGN | Organon & Co. | 3.52B | 0.07% | 2,098,812 | 6.16B |
| 179 | WRBY | Warby Parker Inc. | 3.50B | -0.59% | 2,052,484 | 890.57M |
| 180 | ORKA | Oruka Therapeutics, Inc. | 3.50B | -6.39% | 1,394,020 | - |
| 181 | TLX | Telix Pharmaceuticals Limited | 3.46B | -2.56% | 71,565 | 803.79M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.41B | -4.20% | 537,891 | - |
| 183 | CON | Concentra Group Holdings Parent, Inc. | 3.36B | 1.51% | 299,187 | 2.23B |
| 184 | ALHC | Alignment Healthcare, Inc. | 3.34B | 2.86% | 2,010,965 | 4.26B |
| 185 | VCYT | Veracyte, Inc. | 3.34B | 8.68% | 999,190 | 541.74M |
| 186 | VKTX | Viking Therapeutics, Inc. | 3.30B | -5.98% | 2,588,394 | - |
| 187 | BKD | Brookdale Senior Living Inc. | 3.17B | 1.88% | 2,034,205 | 3.00B |
| 188 | ERAS | Erasca, Inc. | 3.16B | -0.64% | 1,699,010 | - |
| 189 | OPCH | Option Care Health, Inc. | 3.11B | 1.41% | 1,522,420 | 5.67B |
| 190 | MMED | MiniMed Group, Inc. | 3.10B | 2.08% | 468,534 | 2.99B |
| 191 | TWST | Twist Bioscience Corporation | 3.08B | 0.57% | 783,212 | 409.48M |
| 192 | ITGR | Integer Holdings Corporation | 3.07B | 2.39% | 186,249 | 1.86B |
| 193 | ICUI | ICU Medical, Inc. | 3.06B | 3.29% | 195,667 | 2.16B |
| 194 | NHC | National HealthCare Corporation | 3.06B | 1.25% | 67,428 | 1.53B |
| 195 | LFST | LifeStance Health Group, Inc. | 3.01B | 1.50% | 1,842,234 | 1.49B |
| 196 | GMRS | GMR Solutions Inc. | 3.00B | 0.60% | 403,149 | 5.74B |
| 197 | PRVA | Privia Health Group, Inc. | 2.98B | 3.14% | 374,552 | 2.25B |
| 198 | TNGX | Tango Therapeutics, Inc. | 2.96B | -0.39% | 2,123,258 | 56.99M |
| 199 | RCUS | Arcus Biosciences, Inc. | 2.96B | -1.09% | 782,505 | 236.00M |
| 200 | DNLI | Denali Therapeutics Inc. | 2.91B | -1.50% | 1,134,802 | - |
| 201 | SUPN | Supernus Pharmaceuticals, Inc. | 2.80B | -2.26% | 326,246 | 776.83M |
| 202 | SLNO | Soleno Therapeutics, Inc. | 2.76B | - | - | 285.01M |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.73B | -4.45% | 879,306 | - |
| 204 | TXG | 10x Genomics, Inc. | 2.72B | 1.13% | 1,594,200 | 638.78M |
| 205 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | 0.61% | 296,749 | 535.08M |
| 206 | HAE | Haemonetics Corporation | 2.67B | 2.00% | 330,752 | 1.33B |
| 207 | BEAM | Beam Therapeutics Inc. | 2.64B | -4.94% | 1,227,153 | 164.01M |
| 208 | ALMS | Alumis Inc. | 2.63B | -9.75% | 922,892 | 8.40M |
| 209 | GRAL | GRAIL, Inc. | 2.59B | 1.09% | 298,012 | 156.12M |
| 210 | GPCR | Structure Therapeutics Inc. | 2.55B | -7.20% | 432,713 | - |
| 211 | IRON | Disc Medicine, Inc. | 2.53B | -1.09% | 346,655 | - |
| 212 | ARQT | Arcutis Biotherapeutics, Inc. | 2.50B | -6.17% | 956,260 | 415.62M |
| 213 | KLRA | Kailera Therapeutics, Inc. | 2.48B | -8.89% | 416,553 | - |
| 214 | VERA | Vera Therapeutics, Inc. | 2.48B | -7.32% | 991,251 | - |
| 215 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -0.21% | 520,445 | 225.27M |
| 216 | NBTX | Nanobiotix S.A. | 2.47B | -5.19% | 34,380 | 38.27M |
| 217 | ELVN | Enliven Therapeutics, Inc. | 2.38B | -5.66% | 307,976 | - |
| 218 | RARE | Ultragenyx Pharmaceutical Inc. | 2.37B | -3.48% | 705,232 | 670.00M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.35B | -4.47% | 507,499 | 865.00K |
| 220 | ACHC | Acadia Healthcare Company, Inc. | 2.35B | -1.20% | 776,495 | 3.37B |
| 221 | TMDX | TransMedics Group, Inc. | 2.34B | 7.26% | 1,230,859 | 635.89M |
| 222 | LMAT | LeMaitre Vascular, Inc. | 2.31B | 3.97% | 325,247 | 256.28M |
| 223 | RLAY | Relay Therapeutics, Inc. | 2.31B | -1.23% | 1,645,275 | 10.68M |
| 224 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.28B | -0.50% | 1,981,869 | 885.72M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.26B | -2.43% | 124,725 | 1.46B |
| 226 | IMNM | Immunome, Inc. | 2.26B | -4.60% | 898,909 | 4.02M |
| 227 | NKTR | Nektar Therapeutics | 2.26B | -5.35% | 849,733 | 55.63M |
| 228 | DFTX | Definium Therapeutics, Inc. | 2.23B | -2.62% | 913,647 | - |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.22B | 0.45% | 469,607 | 1.09B |
| 230 | AXGN | Axogen, Inc. | 2.22B | 1.63% | 567,297 | 238.11M |
| 231 | HTFL | HeartFlow, Inc. | 2.21B | -9.34% | 845,458 | 191.42M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.18B | -3.69% | 616,538 | - |
| 233 | KOD | Kodiak Sciences Inc. | 2.17B | -6.08% | 481,644 | - |
| 234 | ZLAB | Zai Lab Limited | 2.12B | -8.26% | 1,333,998 | 453.28M |
| 235 | HCM | HUTCHMED (China) Limited | 2.12B | -3.68% | 18,623 | 548.51M |
| 236 | TYRA | Tyra Biosciences, Inc. | 2.09B | -5.29% | 479,710 | - |
| 237 | SEM | Select Medical Holdings Corporation | 2.05B | 0.06% | 572,850 | 5.52B |
| 238 | NVCR | NovoCure Limited | 2.02B | -0.57% | 960,371 | 674.41M |
| 239 | ADPT | Adaptive Biotechnologies Corporation | 2.01B | -1.87% | 1,072,615 | 295.41M |
| 240 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | 1.80% | 742,641 | 298.30M |
| 241 | BHC | Bausch Health Companies Inc. | 1.99B | -1.48% | 564,616 | 10.53B |
| 242 | XRAY | DENTSPLY SIRONA Inc. | 1.99B | -1.29% | 3,498,926 | 3.68B |
| 243 | OMCL | Omnicell, Inc. | 1.97B | 0.60% | 255,301 | 1.23B |
| 244 | ADMA | ADMA Biologics, Inc. | 1.94B | 1.27% | 1,854,463 | 509.86M |
| 245 | ESTA | Establishment Labs Holdings Inc. | 1.93B | -0.23% | 296,647 | 229.58M |
| 246 | ASTH | Astrana Health, Inc. | 1.92B | 1.45% | 255,626 | 3.53B |
| 247 | TRVI | Trevi Therapeutics, Inc. | 1.90B | -5.74% | 1,065,067 | - |
| 248 | PGNY | Progyny, Inc. | 1.90B | 4.34% | 1,187,537 | 1.29B |
| 249 | PHVS | Pharvaris N.V. | 1.89B | -4.90% | 249,146 | - |
| 250 | MESO | Mesoblast Limited | 1.89B | -2.40% | 131,949 | 65.38M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 1.85B | -7.64% | 1,801,017 | 52.04M |
| 252 | NEOG | Neogen Corporation | 1.84B | 3.17% | 1,733,679 | 870.56M |
| 253 | MD | Pediatrix Medical Group, Inc. | 1.83B | 1.73% | 363,074 | 1.93B |
| 254 | SGRY | Surgery Partners, Inc. | 1.82B | 0.75% | 1,114,703 | 3.34B |
| 255 | STOK | Stoke Therapeutics, Inc. | 1.80B | -3.69% | 328,252 | 32.08M |
| 256 | CLOV | Clover Health Investments, Corp. | 1.80B | -1.73% | 6,938,744 | 2.21B |
| 257 | LKFT | Lakefront Biotherapeutics NV | 1.79B | -1.07% | 169,088 | 1.20B |
| 258 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | -3.36% | 1,726,572 | 2.18B |
| 259 | ZYME | Zymeworks Inc. | 1.78B | 1.71% | 535,213 | 81.26M |
| 260 | VRDN | Viridian Therapeutics, Inc. | 1.77B | -4.82% | 1,609,359 | 70.92M |
| 261 | AAPG | Ascentage Pharma Group International | 1.77B | -0.24% | 8,471 | 82.08M |
| 262 | VCEL | Vericel Corporation | 1.77B | 4.65% | 329,384 | 292.09M |
| 263 | SION | Sionna Therapeutics, Inc. | 1.76B | -2.96% | 212,727 | - |
| 264 | PLSE | Pulse Biosciences, Inc. | 1.74B | 2.57% | 330,028 | 751.00K |
| 265 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | -3.41% | 865,211 | 217.17M |
| 266 | SNDA | Sonida Senior Living, Inc. | 1.73B | -2.04% | 340,689 | 367.34M |
| 267 | HRMY | Harmony Biosciences Holdings, Inc. | 1.73B | -0.93% | 293,384 | 899.11M |
| 268 | GENB | Generate Biomedicines, Inc. | 1.73B | -15.38% | 1,556,692 | 30.30M |
| 269 | ANAB | AnaptysBio, Inc. | 1.71B | -6.94% | 340,893 | 232.39M |
| 270 | NTLA | Intellia Therapeutics, Inc. | 1.71B | -10.61% | 6,531,885 | 66.09M |
| 271 | ADUS | Addus HomeCare Corporation | 1.70B | 2.37% | 142,598 | 1.45B |
| 272 | AVAH | Aveanna Healthcare Holdings Inc. | 1.69B | 0.71% | 1,617,667 | 2.52B |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | 1.45% | 94,562 | 923.71M |
| 274 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | 0.11% | 361,111 | 66.05M |
| 275 | RAPP | Rapport Therapeutics, Inc. | 1.68B | -5.45% | 141,571 | 20.00M |
| 276 | UFPT | UFP Technologies, Inc. | 1.67B | 1.07% | 144,706 | 608.85M |
| 277 | OCS | Oculis Holding AG | 1.65B | -7.76% | 299,447 | 1.40M |
| 278 | NRIX | Nurix Therapeutics, Inc. | 1.64B | -0.09% | 1,711,470 | 71.78M |
| 279 | INVA | Innoviva, Inc. | 1.62B | 0.02% | 418,086 | 420.69M |
| 280 | STAA | STAAR Surgical Company | 1.62B | 1.37% | 670,016 | 290.38M |
| 281 | CAPR | Capricor Therapeutics, Inc. | 1.60B | -3.79% | 575,027 | 11.13M |
| 282 | AHG | Akso Health Group | 1.58B | 6.65% | 16,281 | 14.84M |
| 283 | QURE | uniQure N.V. | 1.56B | -8.80% | 1,335,573 | 18.09M |
| 284 | TSHA | Taysha Gene Therapies, Inc. | 1.55B | -9.56% | 1,568,074 | 7.47M |
| 285 | RXRX | Recursion Pharmaceuticals, Inc. | 1.53B | -1.37% | 14,481,543 | 66.41M |
| 286 | ATAI | AtaiBeckley Inc. | 1.52B | 2.86% | 6,867,964 | 3.49M |
| 287 | GLUE | Monte Rosa Therapeutics, Inc. | 1.51B | -1.43% | 332,409 | 42.95M |
| 288 | PVLA | Palvella Therapeutics, Inc. | 1.50B | -8.26% | 192,958 | - |
| 289 | IOVA | Iovance Biotherapeutics, Inc. | 1.50B | -2.46% | 8,000,531 | 285.61M |
| 290 | ARDX | Ardelyx, Inc. | 1.50B | -2.41% | 2,377,813 | 427.68M |
| 291 | PRGO | Perrigo Company plc | 1.49B | 1.23% | 1,240,930 | 4.18B |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.48B | 0.08% | 160,616 | - |
| 293 | INBX | Inhibrx Biosciences, Inc. | 1.48B | -7.09% | 279,060 | 1.30M |
| 294 | HCSG | Healthcare Services Group, Inc. | 1.48B | 1.51% | 190,034 | 1.85B |
| 295 | MBX | MBX Biosciences, Inc. | 1.48B | -4.50% | 677,603 | - |
| 296 | ALMR | Alamar Biosciences, Inc. | 1.47B | -1.30% | 224,384 | 87.16M |
| 297 | PRCT | PROCEPT BioRobotics Corporation | 1.47B | -1.03% | 1,099,333 | 322.02M |
| 298 | NUVB | Nuvation Bio Inc. | 1.46B | -2.66% | 3,191,924 | 143.05M |
| 299 | GHRS | GH Research PLC | 1.46B | -0.58% | 321,421 | - |
| 300 | VIR | Vir Biotechnology, Inc. | 1.46B | -1.59% | 934,979 | 65.50M |
| 301 | NVAX | Novavax, Inc. | 1.45B | -2.59% | 3,676,697 | 596.34M |
| 302 | ARDT | Ardent Health, Inc. | 1.45B | 0.20% | 222,599 | 6.43B |
| 303 | ENOV | Enovis Corporation | 1.45B | 3.60% | 765,650 | 2.28B |
| 304 | ATRC | AtriCure, Inc. | 1.44B | 1.40% | 416,972 | 552.16M |
| 305 | IMCR | Immunocore Holdings plc | 1.44B | 0.96% | 132,510 | 412.81M |
| 306 | PGEN | Precigen, Inc. | 1.44B | -8.60% | 3,556,502 | 31.60M |
| 307 | AHCO | AdaptHealth Corp. | 1.43B | 0.56% | 723,465 | 3.29B |
| 308 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.06% | 1,561,234 | 114.48M |
| 309 | IMTX | Immatics N.V. | 1.42B | -2.85% | 438,904 | 43.00M |
| 310 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.41B | -4.25% | 679,388 | -665.00K |
| 311 | AGL | agilon health, inc. | 1.41B | 3.18% | 300,928 | 5.82B |
| 312 | CMPS | COMPASS Pathways plc | 1.40B | 0.24% | 5,991,322 | - |
| 313 | URGN | UroGen Pharma Ltd. | 1.39B | -0.90% | 427,740 | 140.49M |
| 314 | PAHC | Phibro Animal Health Corporation | 1.39B | -0.44% | 225,182 | 1.50B |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.34B | -5.05% | 408,953 | 20.00M |
| 316 | SLS | SELLAS Life Sciences Group, Inc. | 1.34B | 1.91% | 7,630,924 | - |
| 317 | BHVN | Biohaven Ltd. | 1.29B | -2.51% | 1,264,248 | - |
| 318 | BCAX | Bicara Therapeutics Inc. | 1.28B | -3.95% | 358,406 | - |
| 319 | FTRE | Fortrea Holdings Inc. | 1.27B | -1.61% | 503,125 | 2.71B |
| 320 | NNNN | Anbio Biotechnology | 1.26B | 6.61% | 24,687 | 8.65M |
| 321 | ATEC | Alphatec Holdings, Inc. | 1.26B | 6.85% | 2,335,253 | 787.08M |
| 322 | ABCL | AbCellera Biologics Inc. | 1.26B | 0.61% | 9,881,797 | 79.21M |
| 323 | SVRA | Savara Inc. | 1.25B | -1.99% | 1,492,105 | - |
| 324 | WGS | GeneDx Holdings Corp. | 1.24B | 2.75% | 1,101,073 | 442.68M |
| 325 | AVBP | ArriVent BioPharma, Inc. | 1.24B | -4.45% | 173,285 | - |
| 326 | WVE | Wave Life Sciences Ltd. | 1.23B | -5.61% | 4,618,754 | 71.80M |
| 327 | PNTG | The Pennant Group, Inc. | 1.23B | -0.89% | 81,396 | 1.02B |
| 328 | INSP | Inspire Medical Systems, Inc. | 1.21B | 5.07% | 853,089 | 915.25M |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.20B | -8.08% | 384,622 | - |
| 330 | MLTX | MoonLake Immunotherapeutics | 1.19B | -7.18% | 649,627 | - |
| 331 | SEPN | Septerna, Inc. | 1.18B | -2.63% | 221,907 | 72.26M |
| 332 | IVA | Inventiva S.A. | 1.16B | -7.90% | 129,773 | 7.94M |
| 333 | AVNS | Avanos Medical, Inc. | 1.16B | 0.08% | 437,427 | 715.90M |
| 334 | HROW | Harrow, Inc. | 1.15B | -0.93% | 461,157 | 268.68M |
| 335 | COAG | Hemab Therapeutics Holdings, Inc. | 1.15B | -7.27% | 84,661 | - |
| 336 | TDOC | Teladoc Health, Inc. | 1.15B | 0.16% | 2,021,341 | 2.51B |
| 337 | AORT | Artivion, Inc. | 1.15B | 3.95% | 676,290 | 458.69M |
| 338 | KMTS | Kestra Medical Technologies, Ltd. | 1.15B | -0.81% | 195,894 | 83.72M |
| 339 | OLMA | Olema Pharmaceuticals, Inc. | 1.14B | -4.12% | 991,233 | - |
| 340 | AMN | AMN Healthcare Services, Inc. | 1.13B | 1.75% | 407,979 | 3.42B |
| 341 | DBVT | DBV Technologies S.A. | 1.13B | -4.78% | 123,328 | 5.74M |
| 342 | IRMD | IRADIMED CORPORATION | 1.12B | 1.62% | 73,665 | 86.28M |
| 343 | IART | Integra LifeSciences Holdings Corporation | 1.11B | 1.13% | 488,918 | 1.64B |
| 344 | AVLN | Avalyn Pharma Inc. | 1.11B | -11.26% | 274,847 | - |
| 345 | COLL | Collegium Pharmaceutical, Inc. | 1.10B | 0.43% | 199,718 | 796.33M |
| 346 | CNMD | CONMED Corporation | 1.10B | 2.59% | 232,727 | 1.37B |
| 347 | NEO | NeoGenomics, Inc. | 1.09B | 1.82% | 750,787 | 745.97M |
| 348 | BLFS | BioLife Solutions, Inc. | 1.09B | 7.47% | 636,396 | 101.66M |
| 349 | JBIO | Jade Biosciences, Inc. | 1.08B | -6.14% | 269,011 | - |
| 350 | CDNA | CareDx, Inc. | 1.06B | 2.28% | 531,326 | 412.82M |
| 351 | AKTS | Aktis Oncology, Inc. | 1.04B | -3.38% | 100,339 | 8.28M |
| 352 | ZBIO | Zenas BioPharma, Inc. | 1.04B | -10.09% | 570,694 | 10.00M |
| 353 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.04B | -3.13% | 1,258,712 | 204.73M |
| 354 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -4.01% | 1,016,124 | 314.85M |
| 355 | ALVO | Alvotech | 1.02B | -1.96% | 248,150 | 562.04M |
| 356 | CRVS | Corvus Pharmaceuticals, Inc. | 1.01B | -2.60% | 2,143,652 | - |
| 357 | BFLY | Butterfly Network, Inc. | 998.16M | -0.39% | 2,100,579 | 102.92M |
| 358 | INNV | InnovAge Holding Corp. | 997.66M | 3.23% | 162,173 | 949.17M |
| 359 | USPH | U.S. Physical Therapy, Inc. | 994.40M | 4.03% | 234,171 | 787.69M |
| 360 | EYPT | EyePoint, Inc. | 988.49M | -4.53% | 491,059 | 7.61M |
| 361 | CRON | Cronos Group Inc. | 987.05M | -0.57% | 569,104 | 159.54M |
| 362 | OMDA | Omada Health, Inc. | 975.55M | -0.91% | 692,424 | 283.30M |
| 363 | EVO | Evotec SE | 953.92M | 1.48% | 47,734 | 859.03M |
| 364 | LXRX | Lexicon Pharmaceuticals, Inc. | 937.06M | -5.38% | 1,834,982 | 69.64M |
| 365 | PHAT | Phathom Pharmaceuticals, Inc. | 935.69M | -0.76% | 689,634 | 204.89M |
| 366 | MNKD | MannKind Corporation | 929.94M | -2.59% | 3,562,370 | 360.78M |
| 367 | TNDM | Tandem Diabetes Care, Inc. | 927.20M | 5.54% | 3,590,141 | 1.03B |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 926.17M | -4.20% | 1,591,751 | - |
| 369 | SDGR | Schrödinger, Inc. | 904.12M | 1.26% | 719,976 | 254.91M |
| 370 | PHAR | Pharming Group N.V. | 892.68M | -4.10% | 14,935 | 369.49M |
| 371 | INMD | InMode Ltd. | 892.09M | 1.29% | 580,757 | 374.64M |
| 372 | PCRX | Pacira BioSciences, Inc. | 883.48M | -0.83% | 149,544 | 734.86M |
| 373 | BVS | Bioventus Inc. | 882.13M | -0.19% | 278,783 | 576.30M |
| 374 | DRTS | Alpha Tau Medical Ltd. | 874.38M | -4.10% | 797,252 | - |
| 375 | TALK | Talkspace, Inc. | 870.23M | -0.10% | 865,810 | 238.37M |
| 376 | ETON | Eton Pharmaceuticals, Inc. | 864.64M | 4.31% | 225,171 | 86.93M |
| 377 | MGTX | MeiraGTx Holdings plc | 858.95M | -1.33% | 368,656 | 79.76M |
| 378 | NUTX | Nutex Health Inc. | 854.39M | -1.69% | 102,707 | 879.95M |
| 379 | OMER | Omeros Corporation | 854.03M | -3.67% | 1,402,906 | 9.89M |
| 380 | OPK | OPKO Health, Inc. | 853.25M | 2.73% | 1,693,392 | 581.12M |
| 381 | GDRX | GoodRx Holdings, Inc. | 846.69M | 2.88% | 1,717,388 | 787.89M |
| 382 | JANX | Janux Therapeutics, Inc. | 846.46M | -0.07% | 399,755 | 13.73M |
| 383 | SANA | Sana Biotechnology, Inc. | 844.61M | -1.14% | 2,028,419 | - |
| 384 | TBPH | Theravance Biopharma, Inc. | 837.22M | 0.12% | 230,163 | 109.78M |
| 385 | ODTX | Odyssey Therapeutics, Inc. | 828.38M | -0.34% | 205,254 | 2.98M |
| 386 | ABUS | Arbutus Biopharma Corporation | 823.73M | -1.65% | 609,746 | 191.45M |
| 387 | AURA | Aura Biosciences, Inc. | 821.73M | -3.75% | 685,227 | - |
| 388 | ORIC | ORIC Pharmaceuticals, Inc. | 817.79M | -3.07% | 862,409 | - |
| 389 | XNCR | Xencor, Inc. | 817.78M | -1.69% | 575,387 | 97.36M |
| 390 | ESPR | Esperion Therapeutics, Inc. | 807.05M | 0.48% | 10,855,237 | 418.24M |
| 391 | KURA | Kura Oncology, Inc. | 806.96M | -1.41% | 596,936 | 71.64M |
| 392 | ANNX | Annexon, Inc. | 805.29M | -5.66% | 2,327,234 | - |
| 393 | SPTX | Seaport Therapeutics, Inc. | 798.07M | -10.44% | 266,539 | - |
| 394 | AVTX | Avalo Therapeutics, Inc. | 797.17M | -8.40% | 1,756,892 | 59.00K |
| 395 | SSII | SS Innovations International, Inc. | 789.76M | 2.33% | 21,165 | 48.47M |
| 396 | GERN | Geron Corporation | 789.07M | -4.65% | 7,186,987 | 196.12M |
| 397 | LBRX | LB Pharmaceuticals Inc | 789.04M | -7.23% | 139,190 | - |
| 398 | EVMN | Evommune, Inc. | 781.60M | -5.32% | 319,848 | 10.00M |
| 399 | ABSI | Absci Corporation | 773.29M | -3.31% | 2,430,025 | 1.84M |
| 400 | VOR | Vor Biopharma Inc. | 766.19M | -3.35% | 638,066 | - |
| 401 | CTMX | CytomX Therapeutics, Inc. | 760.87M | -3.19% | 2,199,890 | 35.54M |
| 402 | ANRO | Alto Neuroscience, Inc. | 758.89M | -5.79% | 569,338 | - |
| 403 | AMPH | Amphastar Pharmaceuticals, Inc. | 753.55M | 1.30% | 453,286 | 720.53M |
| 404 | AZTA | Azenta, Inc. | 748.09M | 1.31% | 1,590,996 | 596.48M |
| 405 | SGP | SpyGlass Pharma, Inc. | 747.08M | -3.71% | 27,008 | - |
| 406 | QDEL | QuidelOrtho Corporation | 729.64M | 3.68% | 1,340,579 | 2.66B |
| 407 | DRUG | Bright Minds Biosciences Inc. | 728.19M | -4.21% | 321,605 | - |
| 408 | SPRY | ARS Pharmaceuticals, Inc. | 723.92M | -1.82% | 1,520,188 | 98.99M |
| 409 | CERT | Certara, Inc. | 709.37M | 1.79% | 1,770,693 | 419.75M |
| 410 | HSTM | HealthStream, Inc. | 691.52M | 4.27% | 179,648 | 311.78M |
| 411 | PSNL | Personalis, Inc. | 691.16M | 3.77% | 1,850,173 | 64.52M |
| 412 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 690.68M | 1.41% | 375,229 | - |
| 413 | AVR | Anteris Technologies Global Corp. | 684.71M | 1.24% | 631,659 | 1.85M |
| 414 | BIOA | BioAge Labs, Inc. | 684.57M | -12.80% | 342,259 | 10.32M |
| 415 | TENX | Tenax Therapeutics, Inc. | 671.21M | -4.84% | 702,776 | - |
| 416 | DSGN | Design Therapeutics, Inc. | 660.79M | -26.37% | 5,795,372 | - |
| 417 | ALLO | Allogene Therapeutics, Inc. | 659.25M | -4.50% | 4,650,459 | 22.00K |
| 418 | SIBN | SI-BONE, Inc. | 658.59M | 4.87% | 361,687 | 206.22M |
| 419 | RLMD | Relmada Therapeutics, Inc. | 657.65M | -9.13% | 1,585,541 | - |
| 420 | SLDB | Solid Biosciences Inc. | 637.95M | -6.36% | 723,114 | - |
| 421 | LMRI | Lumexa Imaging Holdings, Inc. | 636.05M | -5.83% | 1,042,197 | 1.03B |
| 422 | CBLL | CeriBell, Inc. | 629.85M | 1.84% | 229,470 | 95.07M |
| 423 | ACRS | Aclaris Therapeutics, Inc. | 628.49M | -0.44% | 1,119,311 | 8.37M |
| 424 | TRAX | First Tracks Biotherapeutics, Inc. | 623.53M | 5.74% | 231,789 | - |
| 425 | ZVRA | Zevra Therapeutics, Inc. | 621.30M | -4.54% | 1,989,908 | 122.29M |
| 426 | EIKN | Eikon Therapeutics, Inc. | 614.47M | -14.34% | 660,702 | - |
| 427 | TLRY | Tilray Brands, Inc. | 614.31M | -3.20% | 2,908,521 | 858.28M |
| 428 | BWAY | BrainsWay Ltd. | 611.37M | 0.13% | 124,818 | 56.22M |
| 429 | CRMD | CorMedix Inc. | 608.00M | 2.65% | 1,582,887 | 400.05M |
| 430 | CBIO | Crescent Biopharma, Inc. | 595.46M | -10.27% | 332,783 | 11.88M |
| 431 | CSTL | Castle Biosciences, Inc. | 591.74M | 1.99% | 280,281 | 339.92M |
| 432 | GYRE | Gyre Therapeutics, Inc. | 588.44M | -1.68% | 64,769 | 117.05M |
| 433 | CADL | Candel Therapeutics, Inc. | 575.17M | -10.49% | 3,533,641 | - |
| 434 | ARVN | Arvinas, Inc. | 570.04M | -2.70% | 606,826 | 89.40M |
| 435 | STRO | Sutro Biopharma, Inc. | 569.27M | -11.83% | 329,979 | 99.61M |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 566.27M | -3.91% | 1,741,263 | 361.51M |
| 437 | PHR | Phreesia, Inc. | 554.16M | 3.99% | 935,244 | 480.59M |
| 438 | VALN | Valneva SE | 544.53M | -0.18% | 7,632 | 180.25M |
| 439 | NPCE | NeuroPace, Inc. | 541.75M | 3.45% | 105,482 | 99.53M |
| 440 | TCMD | Tactile Systems Technology, Inc. | 537.41M | 4.77% | 177,009 | 343.52M |
| 441 | MDXG | MiMedx Group, Inc. | 536.20M | 1.12% | 813,188 | 389.42M |
| 442 | ALT | Altimmune, Inc. | 534.80M | -3.51% | 2,494,670 | 36.00K |
| 443 | FBRX | Forte Biosciences, Inc. | 527.77M | -9.95% | 218,869 | - |
| 444 | CABA | Cabaletta Bio, Inc. | 526.65M | -2.42% | 1,883,079 | - |
| 445 | XOMA | XOMA Royalty Corporation | 522.71M | -0.17% | 70,001 | 48.56M |
| 446 | TECX | Tectonic Therapeutic, Inc. | 520.41M | -1.11% | 283,253 | - |
| 447 | RIGL | Rigel Pharmaceuticals, Inc. | 518.43M | -3.41% | 296,283 | 299.77M |
| 448 | AQST | Aquestive Therapeutics, Inc. | 516.23M | -1.32% | 2,230,652 | 50.27M |
| 449 | KYTX | Kyverna Therapeutics, Inc. | 512.09M | -10.85% | 1,198,787 | - |
| 450 | AGMB | AgomAb Therapeutics NV | 505.78M | -2.65% | 56,791 | - |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 452 | PRME | Prime Medicine, Inc. | 503.92M | -4.78% | 3,003,533 | 4.03M |
| 453 | PRTA | Prothena Corporation plc | 499.97M | -2.15% | 435,939 | 57.94M |
| 454 | OFIX | Orthofix Medical Inc. | 493.95M | 1.75% | 178,651 | 825.37M |
| 455 | CERS | Cerus Corporation | 488.90M | 4.27% | 1,532,384 | 216.56M |
| 456 | PROK | ProKidney Corp. | 487.67M | -2.71% | 871,709 | 889.00K |
| 457 | ANL | Adlai Nortye Ltd. | 486.20M | -10.03% | 138,467 | 5.00M |
| 458 | CTNM | Contineum Therapeutics, Inc. | 483.03M | -5.83% | 98,874 | - |
| 459 | DNA | Ginkgo Bioworks Holdings, Inc. | 482.09M | -4.28% | 739,401 | 151.40M |
| 460 | ACHV | Achieve Life Sciences, Inc. | 481.47M | -11.34% | 2,063,207 | - |
| 461 | AUTL | Autolus Therapeutics plc | 479.06M | 10.43% | 5,299,186 | 92.62M |
| 462 | IMMX | Immix Biopharma, Inc. | 477.11M | -9.46% | 418,292 | - |
| 463 | KIDS | OrthoPediatrics Corp. | 467.47M | 2.71% | 85,351 | 243.30M |
| 464 | SRTA | Strata Critical Medical, Inc. | 463.78M | 2.68% | 890,283 | 228.58M |
| 465 | CLYM | Climb Bio, Inc. | 462.40M | -10.37% | 512,729 | - |
| 466 | ANGO | AngioDynamics, Inc. | 461.00M | 2.69% | 139,385 | 313.73M |
| 467 | UPB | Upstream Bio, Inc. | 459.30M | -7.15% | 313,185 | 3.32M |
| 468 | CTKB | Cytek Biosciences, Inc. | 457.81M | 4.11% | 964,353 | 204.17M |
| 469 | FLGT | Fulgent Genetics, Inc. | 453.27M | 1.66% | 269,832 | 320.35M |
| 470 | OCGN | Ocugen, Inc. | 451.93M | -3.96% | 5,314,438 | 4.47M |
| 471 | KMDA | Kamada Ltd. | 451.71M | 1.30% | 73,736 | 181.68M |
| 472 | EVH | Evolent Health, Inc. | 451.61M | 1.39% | 1,343,109 | 1.89B |
| 473 | STTK | Shattuck Labs, Inc. | 445.93M | -5.75% | 514,671 | 1.00M |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 441.18M | -7.16% | 446,638 | 251.00K |
| 475 | PRLD | Prelude Therapeutics Incorporated | 437.51M | -2.90% | 372,807 | 16.72M |
| 476 | VTVT | vTv Therapeutics Inc. | 434.95M | -1.81% | 42,469 | 36.84M |
| 477 | FDMT | 4D Molecular Therapeutics, Inc. | 431.28M | -9.84% | 655,784 | 88.24M |
| 478 | ASMB | Assembly Biosciences, Inc. | 431.17M | -5.31% | 159,300 | 71.10M |
| 479 | EOLS | Evolus, Inc. | 431.02M | 0.69% | 715,715 | 301.79M |
| 480 | WEAV | Weave Communications, Inc. | 430.85M | 2.56% | 611,400 | 248.72M |
| 481 | NGNE | Neurogene Inc. | 428.39M | -9.09% | 133,300 | 925.00K |
| 482 | PRTC | PureTech Health plc | 427.39M | -3.79% | 5,253 | 4.66M |
| 483 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.36M | -3.18% | 112,866 | - |
| 484 | NRC | NRC Health | 425.94M | 1.50% | 66,840 | 138.64M |
| 485 | CCRN | Cross Country Healthcare, Inc. | 424.20M | -0.08% | 1,335,440 | 1.00B |
| 486 | CATX | Perspective Therapeutics, Inc. | 421.97M | -3.90% | 786,038 | 618.00K |
| 487 | EBS | Emergent BioSolutions Inc. | 421.54M | 2.90% | 598,255 | 676.80M |
| 488 | OVID | Ovid Therapeutics Inc. | 417.02M | -8.37% | 1,112,281 | 7.12M |
| 489 | BBNX | Beta Bionics, Inc. | 416.65M | -1.16% | 577,327 | 110.24M |
| 490 | REPL | Replimune Group, Inc. | 416.58M | -3.35% | 3,929,854 | - |
| 491 | FULC | Fulcrum Therapeutics, Inc. | 413.13M | -7.32% | 338,490 | 80.00M |
| 492 | VREX | Varex Imaging Corporation | 411.35M | 1.04% | 396,288 | 857.50M |
| 493 | IPSC | Century Therapeutics, Inc. | 409.40M | -2.99% | 1,026,313 | 109.16M |
| 494 | SGMT | Sagimet Biosciences Inc. | 407.56M | -4.35% | 1,001,259 | - |
| 495 | MOBI | Mobia Medical, Inc. | 403.97M | 2.61% | 36,931 | 32.04M |
| 496 | ADCT | ADC Therapeutics SA | 403.20M | -2.46% | 1,237,313 | 79.18M |
| 497 | ZURA | Zura Bio Limited | 402.29M | -10.17% | 563,564 | - |
| 498 | CGC | Canopy Growth Corporation | 392.95M | -6.54% | 10,011,499 | 203.04M |
| 499 | TOI | The Oncology Institute, Inc. | 390.93M | -1.76% | 715,970 | 545.76M |
| 500 | ENTA | Enanta Pharmaceuticals, Inc. | 389.65M | -0.07% | 174,330 | 69.21M |